- $783.85m
- $875.46m
- $438.96m
- 97
- 59
- 82
- 94
Annual income statement for Ci&T, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 268 | 424 | 447 | 439 |
| Cost of Revenue | |||||
| Gross Profit | — | 94.3 | 148 | 149 | 150 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | — | 222 | 371 | 390 | 383 |
| Operating Profit | 0 | 45.3 | 53 | 57 | 55.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | — | 39 | 38.8 | 41.7 | 43.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0 | 23.3 | 18.7 | 26.4 | 29.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0 | 23.3 | 18.7 | 26.4 | 29.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0 | 23.3 | 18.7 | 26.4 | 29.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | — | 0.177 | 0.139 | 0.215 | 0.247 |